Kulemzin, S.V.; Sergeeva, M.V.; Baranov, K.O.; Gorchakov, A.A.; Guselnikov, S.V.; Belovezhets, T.N.; Volkova, O.Y.; Najakshin, A.M.; Chikaev, N.A.; Danilenko, D.M.;
et al. VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages. J. Pers. Med. 2022, 12, 895.
https://doi.org/10.3390/jpm12060895
AMA Style
Kulemzin SV, Sergeeva MV, Baranov KO, Gorchakov AA, Guselnikov SV, Belovezhets TN, Volkova OY, Najakshin AM, Chikaev NA, Danilenko DM,
et al. VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages. Journal of Personalized Medicine. 2022; 12(6):895.
https://doi.org/10.3390/jpm12060895
Chicago/Turabian Style
Kulemzin, Sergey V., Maria V. Sergeeva, Konstantin O. Baranov, Andrey A. Gorchakov, Sergey V. Guselnikov, Tatyana N. Belovezhets, Olga Yu. Volkova, Alexander M. Najakshin, Nikolai A. Chikaev, Daria M. Danilenko,
and et al. 2022. "VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages" Journal of Personalized Medicine 12, no. 6: 895.
https://doi.org/10.3390/jpm12060895
APA Style
Kulemzin, S. V., Sergeeva, M. V., Baranov, K. O., Gorchakov, A. A., Guselnikov, S. V., Belovezhets, T. N., Volkova, O. Y., Najakshin, A. M., Chikaev, N. A., Danilenko, D. M., & Taranin, A. V.
(2022). VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages. Journal of Personalized Medicine, 12(6), 895.
https://doi.org/10.3390/jpm12060895
